Healthcare -
Biotechnology - NASDAQ - US
$ 0.26
3.09 %
$ 16.8 M
Market Cap
-0.42
P/E
GLYC - SHORT-TERM DEBT
Short-term Debt GLYC - GlycoMimetics, Inc.
742 K
LAST VALUE
-13.95%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR